A simple open source bioinformatic methodology for initial exploration of GPCR ligands’ agonistic/antagonistic properties
Abstract Drug development is an arduous procedure, necessitating testing the interaction of a large number of potential candidates with potential interacting (macro)molecules. Therefore, any method which could provide an initial screening of potential candidate drugs might be of interest for the acc...
Main Authors: | Athanasios A. Panagiotopoulos, Christina Papachristofi, Konstantina Kalyvianaki, Panagiotis Malamos, Panayiotis A. Theodoropoulos, George Notas, Theodora Calogeropoulou, Elias Castanas, Marilena Kampa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.600 |
Similar Items
-
The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects
by: Magdalena Kotańska, et al.
Published: (2021-08-01) -
Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells
by: Miriam Stoeber, et al.
Published: (2020-02-01) -
Expanding the Concept of G Protein-Coupled Receptor (GPCR) Dimer Asymmetry towards GPCR-Interacting Proteins
by: Ralf Jockers, et al.
Published: (2011-01-01) -
Capturing Peptide–GPCR Interactions and Their Dynamics
by: Anette Kaiser, et al.
Published: (2020-10-01) -
Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?
by: Matthieu Colom, et al.
Published: (2019-10-01)